Charlie joined Cushman & Wakefield (formerly DTZ) in 1999. As a Licensed Real Estate Broker, SIOR and CCIM, he leverages his broad experience to advise his clients, both occupiers and investors, in Northern and Central New Jersey. Charlie grew up in Paterson, New Jersey, and prides himself on having an comprehensive knowledge of New Jersey’s geography, and its relation to commercial real estate development.
Charlie focuses on representing both tenants and landlords on office, medical and technology oriented space in Central and Northern New Jersey markets. Charlie has been involved in over three million square feet of deals for both tenants and landlords over the past ten years with an aggregate value of over $280 million. Notable transactions and clients include PTC Therapeutics, Nistica, Inc., Ipsen Biopharmaceuticals, Hunterdon HealthCare, Business Credentialing Services, Johnson & Johnson, Fresenius Medical Care, Advanced Health Media, Furukawa Electric, LSI (formerly Agere Systems), American Arthritis Foundation, Blenheim Capital Management, LabCorp, and Blackwater Capital Management.
•Industrial and Office Real Estate Brokers Association of the New York Metropolitan Area Since 1993 (Advisory Board Member)
•Certified Commercial Investment Member Since 2003 (CCIM)
•Society of Industrial & Office Realtors Since 2004 (SIOR)
•2010 NJ Chapter President of SIOR
Cushman & Wakefield is a global leader in commercial real estate services, helping clients transform the way people work, shop, and live. The firm’s 43,000 employees in more than 60 countries provide deep local and global insights that create significant value for occupiers and investors around the world. Cushman & Wakefield is among the largest commercial real estate services firms with revenues of $5 billion across core services of agency leasing, asset services, capital markets, facility services (branded C&W Services), global occupier services, investment management (branded DTZ Investors), project & development services, tenant representation, and valuation & advisory. To learn more, visit www.cushmanwakefield.com or follow@CushWake on Twitter.